General MedicationsORALGeneric

TRINALIN

AZATADINE MALEATE; PSEUDOEPHEDRINE SULFATE

Standard Dose

1MG;120MG

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview TRINALIN is listed in Drugs@FDA under application 018506 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient AZATADINE MALEATE; PSEUDOEPHEDRINE SULFATE Form and strength TABLET, EXTENDED RELEASE;ORAL - 1MG;120MG Sponsor SCHERING Submission history Latest submission status date: 2002-12-12 00:00:00.

Structured Monograph

Clinical summary

Approval overview TRINALIN is listed in Drugs@FDA under application 018506 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient AZATADINE MALEATE; PSEUDOEPHEDRINE SULFATE Form and strength TABLET, EXTENDED RELEASE;ORAL - 1MG;120MG Sponsor SCHERING Submission history Latest submission status date: 2002-12-12 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.